Kevin Ard is an Infectious Disease physician affiliated with Harvard University. OpenAlex indexes 67 publications with 1,227 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
75 Francis St
Boston, MA 021156110
Telephone
617-525-6841Registry record last updated 11 Mar 2014.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
50%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor18.8%Tivicay54%Isentress46%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor9.7%Descovy100%Part D<11 patients+ 3 more classes in this area
Cardiovascular
29.6%Statin16.7%Atorvastatin Calcium58%Rosuvastatin Calcium42%Part D<11 patientsACE inhibitor7%Lisinopril100%Part D<11 patients+ 1 more class in this area
Musculoskeletal
7.5%Nonsteroidal Anti-inflammatory Drug7.5%Naproxen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2026–2026 per NIH RePORTER. The latest:
- Electronic Partner Notification for STIs: A Syndemic Approach to Improve HIV and STI Service Access in MA
Massachusetts General Hospital
FY2026$855,983R01MH138281
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Changes in Clinic-Level STI Burden After Doxycycline Post-Exposure Prophylaxis Implementation in an Urban Sexual Health Clinic
Sexually Transmitted Diseases
2025 - Increasing Length of the <i>Babesia</i> Season in New England in the Climate Change Era
Open Forum Infectious Diseases
2025 - Laser hair removal to antiretrovirals: findings from a person‐centred care model for transgender people in India
Journal of the International AIDS Society
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Benjamin Ebert, MD
Harvard University
Mark Shrime, MD
Harvard University
Thoralf Sundt, MD
Harvard University
Dhaval Kolte, MBBS, PhD
Harvard University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”